Ginkgo Bioworks

Ginkgo Bioworks

Ginkgo Bioworks is a biotechnology company using machine learning techniques and lab automation to engineer microorganisms as a service.

All edits

Edits on 3 Mar, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 3 Mar, 2021
Edits made to:
Infobox (+2/-2 properties)
Infobox
Latest funding round date
September 2019
Total funding amount (USD)
665,000,000
Latest funding round date
May 28, 2020
Total funding amount (USD)
797,420,000
Edits on 24 Feb, 2021
Golden AI
Golden AI edited on 24 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Ginkgo Bioworks Series F round, May 28, 2020
Golden AI
Golden AI edited on 24 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Ginkgo Bioworks Series B round, July 23, 2015
Golden AI
Golden AI edited on 24 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Ginkgo Bioworks Series A round, March 18, 2015
Golden AI
Golden AI edited on 24 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Ginkgo Bioworks Seed round, July 16, 2014
Golden AI
Golden AI edited on 24 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Ginkgo Bioworks Grant (money), November 1, 2010
Edits on 8 Feb, 2021
Golden AI
Golden AI edited on 8 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Subsidiary
Motif Foodworks
Joseph Burns"Research engine edit"
Joseph Burns edited on 8 Feb, 2021
Edits made to:
Infobox (+1/-1 properties)
Infobox
Legal classification
Incorporate or Limited Liability Company
Legal classification
Incorporation (business)
Golden AI"Infobox creation from: Wikidata data enrichment"
Golden AI approved a suggestion from Golden's AI on 8 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Country
United States
Joseph Burns
Joseph Burns edited on 8 Feb, 2021
Edits made to:
Infobox (+1/--1 properties)
Infobox
Legal classification
Incorporate or Limited Liability Company
Number of Employees (ranges)
500–999
Edits on 8 Jan, 2021
Amy Tomlinson Gayle
Amy Tomlinson Gayle edited on 8 Jan, 2021
Edits made to:
Article (+28/-72 characters)
Article

Ginkgo Bioworks was founded in 2009 by scientists at MIT and is located in Boston, Massachusetts. Ginkgo was co-founded by Tom Knight, synthetic biologist and former computer science research scientist at MIT, Harvard geneticist George Church, biotechnologist Craig Venter, and four MIT biological engineering graduate students, including Ginkgo’s CEO Jason Kelly. Ginkgo Bioworks is an analytics company that designs organisms for customers in a range of industries. It is the self-proclaimed "Organism Company".

...

Ginkgo Bioworks designs microbes in analytical labs it calls synthetic biology foundries, which comprise software and hardware tools that allow for rapid prototyping and high-throughput screening. Several publicly-stated products include chemical intermediates, flavors, and fragrances;, as well as microbes that provide health benefits to the human gut microbiome and agricultural crop root microbiomes.

...

Gingko uses automation to make genetic changes that produce organisms with useful properties. The company uses Python code to pull out sequences that might produce a gene to make a desired product. Robots are used to print out and assemble the DNA and insert them into bacteria or yeast. The bacteria and yeast strains are tested for fitness, efficiency, and yield. Data from this process is captured and used to build design principles to make future engineering of organisms more efficient. With automated robots, one Ginkgo operator can perform around 1000 DNA extractions in a day, compared with about 24 by one graduate student.

...

High throughputHigh-throughput strain improvement is the next step after figuring out how to make cultured ingredients. Strain improvement seeks to increase efficiency, reducesreduce cost, and improve the sustainability of of products made by custom organisms. Enzyme design looks for ways to either use existing enzymes for other purposes, or looks for ways the make enzymes do their job better. Enzymes act as catalysts that speed up biochemical reactions. Examples of the industrial use of enzymes include cheesemaking, pharmaceutical production, and clothing manufacturing. Yeast fermentation to produce perfume scents.

...

Ginkgo opened its Bioworks 4 foundry for engineered mammalian cells in 2018. Their mouse, hamster and human cells can be used to make biomolecules such as antibodies and proteins. The company also prepares cells that will be used as the drug, such as in the case for cancer immunotherapies. The company plans to enable small biotech startups to investigate leads without incurring large costs, and even operate lab-free, similar to how tech companies rely on cloud than building their own server farm.

Edits on 20 Nov, 2020
Henry Ogolla
Henry Ogolla edited on 20 Nov, 2020
Edits made to:
Timeline (+1 events) (+150 characters)
Timeline

November 20, 2020

Ginkgo Bioworks announces it has secured access to at least 10 million rapid antigen test kits from Access Bio, a global in vitro diagnostics company.

Edits on 24 Oct, 2020
Golden AI
Golden AI edited on 24 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Spinout
Allonnia
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
September 2019
Edits on 5 Oct, 2020
Golden AI
Golden AI edited on 5 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Genomatica
Edits on 25 Sep, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 25 Sep, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
565,000,000
Total funding amount (USD)
665,000,000
Golden AI
Golden AI edited on 25 Sep, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Ginkgo Bioworks Series C round, June 2016
Edits on 14 Aug, 2020
Edita Rexha
Edita Rexha approved a suggestion from Golden's AI on 14 Aug, 2020
Edits made to:
Article (+12/-12 characters)
Article

In 2019 Ginkgo entered a $100 million partnership with Cronos GroupCronos Group, the leading Canadian cannabis company. The partnership is for the economically sustainable production of cultured cannabinoids.

Jason D. Rowley"Research engine edit"
Jason D. Rowley edited on 14 Aug, 2020
Edits made to:
Infobox (--1 properties)
Infobox
Company status
Active
Edits on 18 Jun, 2020
Holden Page
Holden Page edited on 18 Jun, 2020
Edits made to:
Article (+12/-12 characters)
Article

Government awards/grants

Award/ Grant
Funding Agency
Value
Year

National Science Foundation

2015$150,000

$150,0002015

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.